First Horizon Advisors, Inc. Catalent, Inc. Transaction History

First Horizon Advisors, Inc.

$3.58 Billion
Q3 2024

A detailed history of First Horizon Advisors, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 445 shares of CTLT stock, worth $28,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares

445

Previous 637 30.14%

Holding current value

$28,248

Previous $35,000 25.71%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$56.16 - $60.96 $10,782 - $11,704	-192 Reduced 30.14%	445 $26,000
Q2 2024 Jul 19, 2024	SELL	$53.58 - $57.02 $34,237 - $36,435	-639 Reduced 50.08%	637 $35,000
Q1 2024 Apr 26, 2024	BUY	$42.56 - $59.82 $2,808 - $3,948	66 Added 5.45%	1,276 $72,000
Q4 2023 Feb 06, 2024	SELL	$32.18 - $46.57 $2,767 - $4,005	-86 Reduced 6.64%	1,210 $54,000
Q3 2023 Oct 27, 2023	BUY	$44.2 - $50.2 $2,563 - $2,911	58 Added 4.68%	1,296 $59,000
Q2 2023 Aug 03, 2023	SELL	$31.86 - $67.26 $34,982 - $73,851	-1,098 Reduced 47.0%	1,238 $53,000
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $5,452 - $8,911	120 Added 5.42%	2,336 $153,000
Q4 2022 Feb 10, 2023	SELL	$41.39 - $81.0 $18,294 - $35,802	-442 Reduced 16.63%	2,216 $99,000
Q3 2022 Nov 09, 2022	SELL	$72.36 - $113.1 $23,372 - $36,531	-323 Reduced 10.84%	2,658 $192,000
Q2 2022 Aug 02, 2022	BUY	$87.2 - $114.05 $74,468 - $97,398	854 Added 40.15%	2,981 $319,000
Q1 2022 May 10, 2022	SELL	$94.19 - $124.49 $84,676 - $111,916	-899 Reduced 29.71%	2,127 $236,000
Q4 2021 Feb 09, 2022	BUY	$119.57 - $139.07 $18,533 - $21,555	155 Added 5.4%	3,026 $387,000
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $54,475 - $71,032	-499 Reduced 14.81%	2,871 $382,000
Q3 2021 Nov 09, 2021	BUY	$109.17 - $142.35 $280,676 - $365,981	2,571 Added 321.78%	3,370 $448,000
Q2 2021 Aug 09, 2021	BUY	$100.34 - $115.69 $1,404 - $1,619	14 Added 1.78%	799 $86,000
Q1 2021 May 11, 2021	BUY	$101.51 - $125.27 $14,109 - $17,412	139 Added 21.52%	785 $82,000
Q4 2020 Feb 11, 2021	BUY	$85.88 - $105.36 $7,729 - $9,482	90 Added 16.19%	646 $67,000
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $22,112 - $28,120	304 Added 120.63%	556 $47,000
Q2 2020 Jul 31, 2020	SELL	$48.02 - $79.04 $14,694 - $24,186	-306 Reduced 54.84%	252 $18,000
Q1 2020 May 05, 2020	SELL	$36.95 - $62.95 $4,581 - $7,805	-124 Reduced 18.18%	558 $28,000
Q2 2018 Aug 07, 2018	SELL	$38.72 - $42.52 $4,375 - $4,804	-113 Reduced 14.21%	682 $0
Q1 2018 May 02, 2018	BUY	$39.4 - $47.39 $6,895 - $8,293	175 Added 28.23%	795 $0
Q3 2017 Nov 09, 2017	BUY	$33.75 - $41.67 $1,012 - $1,250	30 Added 5.08%	620 $0
Q2 2017 Aug 14, 2017	BUY	N/A	590	590 $0

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Catalent, Inc. Transaction History